These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. St Clair WH, Billings PC, Carew JA, Keller-McGandy C, Newberne P, Kennedy AR. Cancer Res; 1990 Feb 01; 50(3):580-6. PubMed ID: 2297699 [Abstract] [Full Text] [Related]
4. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. Kennedy AR. Am J Clin Nutr; 1998 Dec 01; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508 [Abstract] [Full Text] [Related]
7. Protection against dimethylhydrazine-induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor. Weed HG, McGandy RB, Kennedy AR. Carcinogenesis; 1985 Aug 01; 6(8):1239-41. PubMed ID: 4040444 [Abstract] [Full Text] [Related]
8. The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases. Clemente A, Moreno FJ, Marín-Manzano Mdel C, Jiménez E, Domoney C. Mol Nutr Food Res; 2010 Mar 01; 54(3):396-405. PubMed ID: 19885848 [Abstract] [Full Text] [Related]
10. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells. Ware JH, Wan XS, Kennedy AR. Nutr Cancer; 1999 Mar 01; 33(2):174-7. PubMed ID: 10368813 [Abstract] [Full Text] [Related]
11. Proteases, protease inhibitors and radiation carcinogenesis. Kennedy AR. Int J Radiat Biol; 2023 Mar 01; 99(6):882-890. PubMed ID: 34325613 [Abstract] [Full Text] [Related]
12. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells. Zhang L, Wan XS, Donahue JJ, Ware JH, Kennedy AR. Nutr Cancer; 1999 Mar 01; 33(2):165-73. PubMed ID: 10368812 [Abstract] [Full Text] [Related]
13. Internalisation of the Bowman-Birk protease inhibitor by intestinal epithelial cells. Billings PC, Brandon DL, Habres JM. Eur J Cancer; 1991 Mar 01; 27(7):903-8. PubMed ID: 1834126 [Abstract] [Full Text] [Related]
16. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor. St Clair WH. Carcinogenesis; 1991 May 01; 12(5):935-7. PubMed ID: 2029760 [Abstract] [Full Text] [Related]
17. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors. Yavelow J, Caggana M, Beck KA. Cancer Res; 1987 Mar 15; 47(6):1598-601. PubMed ID: 3545448 [Abstract] [Full Text] [Related]
18. Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis. Ware JH, Wan XS, Newberne P, Kennedy AR. Dig Dis Sci; 1999 May 15; 44(5):986-90. PubMed ID: 10235608 [Abstract] [Full Text] [Related]
19. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity. Malkowicz SB, Liu SP, Broderick GA, Wein AJ, Kennedy AR, Levin RM. Neurourol Urodyn; 2003 May 15; 22(1):54-7. PubMed ID: 12478602 [Abstract] [Full Text] [Related]
20. Acute effects of the Bowman-Birk protease inhibitor in mice. Oreffo VI, Billings PC, Kennedy AR, Witschi H. Toxicology; 1991 May 15; 69(2):165-76. PubMed ID: 1949045 [Abstract] [Full Text] [Related] Page: [Next] [New Search]